Research Briefs
Date of this Version
2-3-2016
Abstract
Genomic testing in patients with early-stage breast cancer is associated with decreased use of chemotherapy and lower costs in younger patients, and slightly increased use of chemotherapy and higher costs in older patients. Genomic testing in actual practice may “rule out” chemotherapy in younger women, and “rule in” chemotherapy in older women.
Document Type
Brief
Number
10
See Original Study
License
This work is licensed under a Creative Commons Attribution-No Derivative Works 4.0 License.
Keywords
personalized medicine and genomics, medical decision making
View On LDI Website
http://ldi.upenn.edu/brief/adjuvant-chemotherapy-use-and-health-care-costs-after-introduction-genomic-testing-breast
Included in
Analytical, Diagnostic and Therapeutic Techniques and Equipment Commons, Health Services Research Commons
Date Posted: 09 December 2016